| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2015.1124996 |
| P698 | PubMed publication ID | 26700494 |
| P50 | author | Swati Garg | Q56816494 |
| P2093 | author name string | Chandrakala Shanmukhaiah | |
| Kanjaksha Ghosh | |||
| Manisha Madkaikar | |||
| P2860 | cites work | Heterogeneity in cancer: cancer stem cells versus clonal evolution | Q29622839 |
| Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells | Q33556931 | ||
| Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML. | Q34924495 | ||
| Deregulation of apoptosis in acute myeloid leukemia | Q36710499 | ||
| Deregulation of signaling pathways in acute myeloid leukemia | Q37240553 | ||
| Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 | ||
| Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Q38164139 | ||
| Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice | Q39206146 | ||
| Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia | Q42208538 | ||
| Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. | Q47929673 | ||
| Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients. | Q54517860 | ||
| P433 | issue | 9 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 2195-2198 | |
| P577 | publication date | 2015-12-24 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia | |
| P478 | volume | 57 |
| Q42123586 | CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML). | cites work | P2860 |
Search more.